Heat Biologics Total Revenue

Heat Biologics (HTBX) currently reports a total revenue of $6.9T as of September 2025. That compares with $830K in the prior-year period — up 837372511.4% year over year. That is above the Healthcare sector average of $110B. Use the charts on this page to explore Heat Biologics's total revenue history and peer comparisons.

Heat Biologics's total revenue increased from $830K to $6.9T — a 837372511.4% year-over-year increase (period ending September 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Heat Biologics's total revenue of $6.9T is higher than the Healthcare sector average of $110B. That is roughly 6067.1% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Heat Biologics reported $6.9T in total revenue as of September 2025. That compares with $830K in the prior-year period — up 837372511.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total revenue of $6.9T, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $110B. From there, open related valuation or income-statement pages for Heat Biologics, and consider following HTBX for alerts when major investors trade the stock.